FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080839 [Registered on: 18/02/2025] Trial Registered Prospectively
Last Modified On: 04/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda
Screening
Other (Specify) [Experimental(in-vitro) ]  
Study Design  Other 
Public Title of Study   IMMUNO - MODULATORY EFFECT OF HINGULA BHASMA 
Scientific Title of Study   Screening of free radical scavenging activity and immuno - modulatory effect of hingula bhasma an experimental study. 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nikita Pandey 
Designation  PG Scholar 
Affiliation  Shri BMK Ayurvedic college Belagavi 
Address  Department of Rasashastra and Bhaishajya Kalpana KAHERs Shri BMK Ayurveda Mahavidalaya shahapur Belagavi Belgaum KARNATAKA 590003 India

Belgaum
KARNATAKA
590003
India 
Phone  8617270963  
Fax    
Email  drnikitapandey12@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr P G Jadar 
Designation  Professor 
Affiliation  KLE Academy of Higher Education & Research Deemed to be University 
Address  Department of Rasashastra and Bhaishajya Kalpana KAHERs Shri BMK Ayurveda Mahavidalaya shahapur Belagavi Belgaum KARNATAKA 590003 India
Department of Rasashastra and Bhaishajya Kalpana KAHERs Shri BMK Ayurveda Mahavidalaya shahapur Belagavi Belgaum KARNATAKA 590003 India
Belgaum
KARNATAKA
590003
India 
Phone  9448301308  
Fax    
Email  drjadar@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr P G Jadar 
Designation  Professor 
Affiliation  KLE Academy of Higher Education & Research Deemed to be University 
Address  Department of Rasashastra and Bhaishajya Kalpana KAHERs Shri BMK Ayurveda Mahavidalaya shahapur Belagavi Belgaum KARNATAKA 590003 India
Department of Rasashastra and Bhaishajya Kalpana KAHERs Shri BMK Ayurveda Mahavidalaya shahapur Belagavi Belgaum KARNATAKA 590003 India
Belgaum
KARNATAKA
590003
India 
Phone  9448301308  
Fax    
Email  drjadar@yahoo.co.in  
 
Source of Monetary or Material Support  
KLE Academy of Higher Education Researches owned Shri B M Kankanawadi Ayurveda Mahavidyalaya and KLE Ayurveda Hospital Shahapur, Belagavi,Pin code 590 003, Karnataka, India  
 
Primary Sponsor  
Name  Dr.Nikita Pandey 
Address  Department of Rasashastra and Bhaishajya Kalpana Shri BMK Ayurveda Mahavidyalaya Shahpur Belagavi 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr P G Jadar  KLE Ayurveda Hospital and Medical Research Centre  Shahapur, Belagavi pin 590 003, Karnataka, India DEPT- Rasa shastra and bhaishajya kalpana, DIV.- Pharmaceutical Room No.- 4
Belgaum
KARNATAKA 
9448301308

drjadar@yahoo.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committeefor Research on Human subject kahers shri B M kankanwadi AyurvedMahavidyalaya & KLE ayurved hospital shahapur , Belagavi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  healthy adult male individuals  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: HINGULA BHASMA, Reference: Mishra sidhi nandan, yogaratnakar, chaukhambhha orientalia, edition 1st Pg-167 , Route: Oral, Dosage Form: Bhasma, Dose: 125(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 1 Months, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Healthy subject 
 
ExclusionCriteria 
Details  1) Metabolic disorders like Diabetic Mellitus, hypertension, immune disorders etc.
2) Subjects in the convalescent phase of any infection.
3) Subjects who are on any medications within the duration of 2 to 3 months.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Provides part of molecular evidence on mode of action of hingul bhasma  72 week 
 
Secondary Outcome  
Outcome  TimePoints 
NILL  NILL 
 
Target Sample Size   Total Sample Size="5"
Sample Size from India="5" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  05/03/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Hingula is Netrarogahara, kaphaprakopanasak, pittaprakopajanya, pleeharogahara, kusthahara, garavishahara and kamalaroga. It Helps in aampachan, agnivardhak, it cures all types of prameha. It improves deha, kanti, bala and budhi. The clinical efficacy studies have proven their indication howerver the free radical scavenging activity and immuno-modulatory effect of Hingula Bhasma is not yet been conducted as per our literature search.  
Close